ARCHIVES

NCAB Hears “Impressive” Progress Reports, Including Treatment for Breast, Liver Cancer, Vaccine Studies

This article is from The Cancer Letter archive.

Vol. 01 No. 37 | October 18, 1974

Download PDF Visit The Full Archive

Related Articles

FDA Selects 23 Survivors To Review Drug Applications.

June 15, 2001

ELM Wins ACCC Management Contract Over ORC, Others

February 21, 1992

Brown Disagrees With Staff, Subgroup On Dichlorvos, Says It Is a Carcinogen

September 2, 1977

Interim Funding: Noncompeting Renewals Reduced By 4 Percent, Competing Current Plus 7 Percent

January 8, 1982

In Brief: Jane Henney, Former NCI Deputy Director, Named FDA Deputy Commissioner For Operations

November 15, 1991

AACR Urges FDA To Speed Approval of Therapies for Precancerous Lesions

November 15, 2002